Kostapanos M S, Liberopoulos E N, Goudevenos J A, Mikhailidis D P, Elisaf M S
Department of Internal Medicine, School of Medicine, University of Ioannina, 451 10 Ioannina, Greece.
Cardiovasc Res. 2007 Jul 1;75(1):10-20. doi: 10.1016/j.cardiores.2007.02.029. Epub 2007 Mar 2.
Sudden cardiac death, which is mainly associated with the presence of life-threatening ventricular arrhythmias, is a common 'killer' among patients with coronary artery disease. Moreover, atrial fibrillation is the most common arrhythmia encountered in the clinical practice. The beneficial effect of statins on cardiovascular morbidity and mortality is well-established, while the exact role of this class of drugs against arrhythmias remains unclear. This review discusses the effect of statin treatment on arrhythmias that are commonly seen in the clinical setting. The underlying pathophysiological mechanisms are also overviewed. Compelling evidence from the majority of the studies reviewed shows that statins exhibit a protective effect against the occurrence of ventricular arrhythmias and atrial fibrillation.
心脏性猝死主要与危及生命的室性心律失常有关,是冠心病患者中常见的“杀手”。此外,心房颤动是临床实践中最常见的心律失常。他汀类药物对心血管发病率和死亡率的有益作用已得到充分证实,而这类药物对抗心律失常的确切作用仍不清楚。本综述讨论了他汀类药物治疗对临床常见心律失常的影响。还概述了潜在的病理生理机制。大多数综述研究的有力证据表明,他汀类药物对室性心律失常和心房颤动的发生具有保护作用。